A detailed history of First Trust Advisors LP transactions in Ardelyx, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 574,307 shares of ARDX stock, worth $2.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
574,307
Previous 652,948 12.04%
Holding current value
$2.92 Million
Previous $4.84 Million 18.23%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.28 - $7.57 $415,224 - $595,312
-78,641 Reduced 12.04%
574,307 $3.96 Million
Q2 2024

Aug 13, 2024

BUY
$5.89 - $9.31 $3.85 Million - $6.08 Million
652,948 New
652,948 $4.84 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $787M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.